Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death worldwide, because recurrence often occurs in most HCC patients undergoing hepatectomy. It is necessary to identify patients with high risk for recurrence and adopt effective therapies. An obstacle to monitor patients at hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Binghua, Feng, Wendu, Luo, Ouyang, Xu, Tiancheng, Cao, Yajuan, Wu, Hongyan, Yu, Decai, Ding, Yitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514049/
https://www.ncbi.nlm.nih.gov/pubmed/28717245
http://dx.doi.org/10.1038/s41598-017-04811-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514049/
https://www.ncbi.nlm.nih.gov/pubmed/28717245
http://dx.doi.org/10.1038/s41598-017-04811-5

Ejemplares similares